Current Treatment Strategy for Newly Diagnosed Chordoma of the Mobile Spine and Sacrum: Results of an International Survey.
Nicolas Dea,Charles G. Fisher,Jeremy J. Reynolds,Joseph H. Schwab,Laurence D. Rhines,Ziya L. Gokaslan,Chetan Bettegowda,Arjun Sahgal,Aron Lazary,Alessandro Luzzati,Stefano Boriani,Alessandro Gasbarrini,Ilya Laufer,Raphaele Charest-Morin,Feng Wei,William Teixeira,Niccole M. Germscheid,Francis J. Hornicek,Thomas F. Delaney,John H. Shin
DOI: https://doi.org/10.3171/2018.6.spine18362
2019-01-01
Journal of Neurosurgery Spine
Abstract:OBJECTIVEThe purpose of this study was to investigate the spectrum of current treatment protocols for managing newly diagnosed chordoma of the mobile spine and sacrum.METHODSA survey on the treatment of spinal chordoma was distributed electronically to members of the AOSpine Knowledge Forum Tumor, including neurosurgeons, orthopedic surgeons, and radiation oncologists from North America, South America, Europe, Asia, and Australia. Survey participants were pre-identified clinicians from centers with expertise in the treatment of spinal tumors. The suvey responses were analyzed using descriptive statistics.RESULTSThirty-nine of 43 (91%) participants completed the survey. Most (80%) indicated that they favor en bloc resection without preoperative neoadjuvant radiation therapy (RT) when en bloc resection is feasible with acceptable morbidity. The main area of disagreement was with the role of postoperative RT, where 41% preferred giving RT only if positive margins were achieved and 38% preferred giving RT irrespective of margin status. When en bloc resection would result in significant morbidity, 33% preferred planned intralesional resection followed by RT, and 33% preferred giving neoadjuvant RT prior to surgery. In total, 8 treatment protocols were identified: 3 in which en bloc resection is feasible with acceptable morbidity and 5 in which en bloc resection would result in significant morbidity.CONCLUSIONSThe results confirm that there is treatment variability across centers worldwide for managing newly diagnosed chordoma of the mobile spine and sacrum. This information will be used to design an international prospective cohort study to determine the most appropriate treatment strategy for patients with spinal chordoma.